Dr. Giancarlo Pasquale Dimassa, MD

Dr. Dimassa practices at Sub-Acute Care Center in Mission Hills, California.

Dr. Dimassa's NPI, 1255370797, was assigned on June 6, 2006. Dr. Dimassa graduated from David Geffen School of Medicine at UCLA in 2001. Dr. Dimassa holds California license A81063.

Dr. Dimassa's primary practice is Sub-Acute Care Center, at 11600a Indian Hills Road, Mission Hills, Ca 91345, Mission Hills, CA 91345 in Los Angeles County. The practice phone is (818) 898-4630. Dr. Dimassa also practices at Providence Holy Cross Medical Center, 15031 W Rinaldi St, Mission Hills, CA 91345.

Dr. Dimassa's primary practice is Sub-Acute Care Center in Mission Hills, California. Dr. Dimassa is also affiliated with Providence Holy Cross Medical Center. The medical group on file is Vituity. Dmand AI also links Dr. Dimassa to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dimassa practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Dimassa's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Dimassa is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Dimassa's licenses on file in 15 states: California, Arizona, Colorado, Montana, New Jersey, Nevada, New York, Florida, Idaho, Illinois, Kansas, Mississippi, North Dakota, Ohio and Tennessee.

CMS data shows 1,310 Medicare services from Dr. Dimassa across 28 procedure codes in 2024, for 538 Medicare patients. Medicare paid $80,457 for them.

CMS counts 538 Medicare patients who saw Dr. Dimassa in 2024. The largest group is 65 to 74, with 219 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dimassa's median patient age at 46, with 60% women.

In 2024, Dr. Dimassa wrote 470 Medicare Part D claims for 303 patients. 88% of them were for generic drugs. CMS names the drug for 256 of them, across 11 drugs with 11 or more claims each, at $22,198 in total drug cost. In 2023, CMS named 300 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Dimassa for performance year 2024, reported as part of a group. Dr. Dimassa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dimassa as offering telehealth.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Dimassa. Dr. Dimassa's most frequent co-authors are Laleh Gharahbaghian, MD and Bobby Massoudian, MD.

CMS Open Payments shows 1 general payment to Dr. Dimassa from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $20.

Dr. Dimassa graduated from David Geffen School of Medicine at UCLA in 2001.

Dr. Dimassa is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.